Skip to Content

TussiCaps Side Effects

Generic Name: chlorpheniramine / hydrocodone

Note: This document contains side effect information about chlorpheniramine / hydrocodone. Some of the dosage forms listed on this page may not apply to the brand name TussiCaps.

For the Consumer

Applies to chlorpheniramine / hydrocodone: oral capsule extended release, oral suspension extended release

Other dosage forms:

Along with its needed effects, chlorpheniramine/hydrocodone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking chlorpheniramine / hydrocodone:

Incidence Not Known

  • Decrease in frequency of urination
  • decrease in urine volume
  • difficult, painful, or troubled breathing
  • difficulty in passing urine (dribbling)
  • irregular, fast or slow, or shallow breathing
  • pale or blue lips, fingernails, or skin
  • tightness in the chest

Some side effects of chlorpheniramine / hydrocodone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence Not Known

  • Drowsiness
  • false or unusual sense of well-being
  • fear or nervousness
  • itching skin or rash
  • nausea
  • sleepiness
  • unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
  • vomiting

For Healthcare Professionals

Applies to chlorpheniramine / hydrocodone: oral capsule extended release, oral liquid, oral suspension extended release

General

The more commonly reported adverse effects have included, sedation, somnolence, mental clouding, dizziness, nausea and vomiting.[Ref]

Respiratory

Frequency not reported: Dose-related respiratory depression including fatal respiratory depression, dryness of the pharynx, dryness of respiratory passages, laryngismus, wheezing, breathing trouble[Ref]

Nervous system

Frequency not reported: Sedation, somnolence, drowsiness, lethargy, mental and physical impairment, dizziness, headache, facial dyskinesia, feeling faint, lightheadedness, tremor[Ref]

Psychiatric

Frequency not reported: Mental clouding, confusion, anxiety, fear, dysphoria, psychic dependence, mood changes, euphoria, agitation, irritability

Gastrointestinal

Frequency not reported: Nausea, vomiting, constipation, abdominal pain, acute pancreatitis, dry mouth, dyspepsia, epigastric distress, loss of appetite[Ref]

Cardiovascular

Frequency not reported: Chest tightness

Dermatologic

Frequency not reported: Skin rash, pruritus, erythema, urticaria, excessive perspiration[Ref]

Genitourinary

Frequency not reported: Ureteral spasm, spasm of vesicle sphincters, urinary retention, dysuria, urinary frequency, urinary hesitancy[Ref]

Ocular

Frequency not reported: Blurred, double, or other visual disturbances

References

1. "Product Information. Tussionex PennKinetic (chlorpheniramine-hydrocodone)." UCB Pharma Inc, Smyrna, GA.

2. "Product Information. Vituz (chlorpheniramine-hydrocodone)." Hawthorn Pharmaceuticals, Madison, MS.

3. "Product Information. HyTan (chlorpheniramine-hydrocodone)." Prasco Laboratories, Cincinnati, OH.

4. "Product Information. TussiCaps (chlorpheniramine-hydrocodone)." ECR Pharmaceuticals, Richmond, VA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide